Biotech reporter Jacob Plieth from EP Vantage speculates Juno Therapeutics (NASDAQ: JUNO) could acquire Bellicum Pharma (NASDAQ: BLCM).From the report:One ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE